172 related articles for article (PubMed ID: 28937220)
1. A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase.
Lahav D; Liu B; van den Berg RJBHN; van den Nieuwendijk AMCH; Wennekes T; Ghisaidoobe AT; Breen I; Ferraz MJ; Kuo CL; Wu L; Geurink PP; Ovaa H; van der Marel GA; van der Stelt M; Boot RG; Davies GJ; Aerts JMFG; Overkleeft HS
J Am Chem Soc; 2017 Oct; 139(40):14192-14197. PubMed ID: 28937220
[TBL] [Abstract][Full Text] [Related]
2. Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.
Ghisaidoobe AT; van den Berg RJ; Butt SS; Strijland A; Donker-Koopman WE; Scheij S; van den Nieuwendijk AM; Koomen GJ; van Loevezijn A; Leemhuis M; Wennekes T; van der Stelt M; van der Marel GA; van Boeckel CA; Aerts JM; Overkleeft HS
J Med Chem; 2014 Nov; 57(21):9096-104. PubMed ID: 25250725
[TBL] [Abstract][Full Text] [Related]
3. β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
Ridley CM; Thur KE; Shanahan J; Thillaiappan NB; Shen A; Uhl K; Walden CM; Rahim AA; Waddington SN; Platt FM; van der Spoel AC
J Biol Chem; 2013 Sep; 288(36):26052-26066. PubMed ID: 23880767
[TBL] [Abstract][Full Text] [Related]
4. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
Walden CM; Sandhoff R; Chuang CC; Yildiz Y; Butters TD; Dwek RA; Platt FM; van der Spoel AC
J Biol Chem; 2007 Nov; 282(45):32655-64. PubMed ID: 17848577
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars.
Ghisaidoobe A; Bikker P; de Bruijn AC; Godschalk FD; Rogaar E; Guijt MC; Hagens P; Halma JM; Van't Hart SM; Luitjens SB; van Rixel VH; Wijzenbroek M; Zweegers T; Donker-Koopman WE; Strijland A; Boot R; van der Marel G; Overkleeft HS; Aerts JM; van den Berg RJ
ACS Med Chem Lett; 2011 Feb; 2(2):119-23. PubMed ID: 24900289
[TBL] [Abstract][Full Text] [Related]
7. Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2.
Boot RG; Verhoek M; Donker-Koopman W; Strijland A; van Marle J; Overkleeft HS; Wennekes T; Aerts JM
J Biol Chem; 2007 Jan; 282(2):1305-12. PubMed ID: 17105727
[TBL] [Abstract][Full Text] [Related]
8. A fluopol-ABPP HTS assay to identify PAD inhibitors.
Knuckley B; Jones JE; Bachovchin DA; Slack J; Causey CP; Brown SJ; Rosen H; Cravatt BF; Thompson PR
Chem Commun (Camb); 2010 Oct; 46(38):7175-7. PubMed ID: 20740228
[TBL] [Abstract][Full Text] [Related]
9. Species-specific differences in nonlysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations.
Woeste MA; Stern S; Raju DN; Grahn E; Dittmann D; Gutbrod K; Dörmann P; Hansen JN; Schonauer S; Marx CE; Hamzeh H; Körschen HG; Aerts JMFG; Bönigk W; Endepols H; Sandhoff R; Geyer M; Berger TK; Bradke F; Wachten D
J Biol Chem; 2019 Mar; 294(11):3853-3871. PubMed ID: 30662006
[TBL] [Abstract][Full Text] [Related]
10. Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitors.
Li KY; Jiang J; Witte MD; Kallemeijn WW; Donker-Koopman WE; Boot RG; Aerts JM; Codée JD; van der Marel GA; Overkleeft HS
Org Biomol Chem; 2014 Oct; 12(39):7786-91. PubMed ID: 25156485
[TBL] [Abstract][Full Text] [Related]
11. Xylose-Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase.
Su Q; Schröder SP; Lelieveld LT; Ferraz MJ; Verhoek M; Boot RG; Overkleeft HS; Aerts JMFG; Artola M; Kuo CL
Chembiochem; 2021 Nov; 22(21):3090-3098. PubMed ID: 34459538
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent-tagged sp2-iminosugars with potent β-glucosidase inhibitory activity.
Aguilar-Moncayo M; García-Moreno MI; Stütz AE; García Fernández JM; Wrodnigg TM; Ortiz Mellet C
Bioorg Med Chem; 2010 Nov; 18(21):7439-45. PubMed ID: 20889348
[TBL] [Abstract][Full Text] [Related]
13. Beta-glucosidase 1 (GBA1) is a second bile acid β-glucosidase in addition to β-glucosidase 2 (GBA2). Study in β-glucosidase deficient mice and humans.
Harzer K; Blech-Hermoni Y; Goldin E; Felderhoff-Mueser U; Igney C; Sidransky E; Yildiz Y
Biochem Biophys Res Commun; 2012 Jun; 423(2):308-12. PubMed ID: 22659419
[TBL] [Abstract][Full Text] [Related]
14. Assay of β-glucosidase 2 (GBA2) activity using lithocholic acid β-3-O-glucoside substrate for cultured fibroblasts and glucosylceramide for brain tissue.
Harzer K; Yildiz Y; Beck-Wödl S
Biol Chem; 2019 May; 400(6):745-752. PubMed ID: 30864417
[TBL] [Abstract][Full Text] [Related]
15. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.
Parmeggiani C; Catarzi S; Matassini C; D'Adamio G; Morrone A; Goti A; Paoli P; Cardona F
Chembiochem; 2015 Sep; 16(14):2054-64. PubMed ID: 26376302
[TBL] [Abstract][Full Text] [Related]
16. The non-lysosomal β-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi.
Körschen HG; Yildiz Y; Raju DN; Schonauer S; Bönigk W; Jansen V; Kremmer E; Kaupp UB; Wachten D
J Biol Chem; 2013 Feb; 288(5):3381-93. PubMed ID: 23250757
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2.
Gu X; Gupta V; Yang Y; Zhu JY; Carlson EJ; Kingsley C; Tash JS; Schönbrunn E; Hawkinson J; Georg GI
ChemMedChem; 2017 Dec; 12(23):1977-1984. PubMed ID: 28975712
[TBL] [Abstract][Full Text] [Related]
18. Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.
Lelieveld LT; Mirzaian M; Kuo CL; Artola M; Ferraz MJ; Peter REA; Akiyama H; Greimel P; van den Berg RJBHN; Overkleeft HS; Boot RG; Meijer AH; Aerts JMFG
J Lipid Res; 2019 Nov; 60(11):1851-1867. PubMed ID: 31562193
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.
van den Berg RJ; van Rijssel ER; Ferraz MJ; Houben J; Strijland A; Donker-Koopman WE; Wennekes T; Bonger KM; Ghisaidoobe AB; Hoogendoorn S; van der Marel GA; Codée JD; Overkleeft HS; Aerts JM
ChemMedChem; 2015 Dec; 10(12):2042-62. PubMed ID: 26492941
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of eight- and four-membered iminosugar analogues as inhibitors of testicular ceramide-specific glucosyltransferase, testicular β-glucosidase 2, and other glycosidases.
Lee JC; Francis S; Dutta D; Gupta V; Yang Y; Zhu JY; Tash JS; Schönbrunn E; Georg GI
J Org Chem; 2012 Apr; 77(7):3082-98. PubMed ID: 22432895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
